These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3930844)

  • 1. Thiamine-responsive inborn errors of metabolism.
    Duran M; Wadman SK
    J Inherit Metab Dis; 1985; 8 Suppl 1():70-5. PubMed ID: 3930844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vitamin B1 dependency].
    Kuroda Y; Naito E
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):225-8. PubMed ID: 9645049
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of thiamin in maple syrup urine disease.
    Elsas LJ; Danner DJ
    Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity.
    Abboud MR; Alexander D; Najjar SS
    J Pediatr; 1985 Oct; 107(4):537-41. PubMed ID: 4045602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
    Chuang DT; Ku LS; Cox RP
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
    Chuang JL; Cox RP; Chuang DT
    J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical basis of thiamin-responsive maple syrup urine disease.
    Chuang DT; Ku LS; Cox RP
    Trans Assoc Am Physicians; 1982; 95():196-204. PubMed ID: 7182976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence of the E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease.
    Zhang B; Wappner RS; Brandt IK; Harris RA; Crabb DW
    Am J Hum Genet; 1990 Apr; 46(4):843-6. PubMed ID: 2316528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiamine-responsive anemia in DIDMOAD syndrome.
    Borgna-Pignatti C; Marradi P; Pinelli L; Monetti N; Patrini C
    J Pediatr; 1989 Mar; 114(3):405-10. PubMed ID: 2537896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids.
    Jouvet P; Kozma M; Mehmet H
    Ann N Y Acad Sci; 2000; 926():116-21. PubMed ID: 11193026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A distinct variant of intermediate maple syrup urine disease.
    Gonzalez-Rios MC; Chuang DT; Cox RP; Schmidt K; Knopf K; Packman S
    Clin Genet; 1985 Feb; 27(2):153-9. PubMed ID: 3978850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease.
    Wendel U; Langenbeck U; Seakins JW
    Pediatr Res; 1989 Jan; 25(1):11-4. PubMed ID: 2919111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.
    Chuang DT; Ku LS; Kerr DS; Cox RP
    Am J Hum Genet; 1982 May; 34(3):416-24. PubMed ID: 7081220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maple syrup urine disease].
    Indo Y; Matsuda I
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):201-4. PubMed ID: 9590028
    [No Abstract]   [Full Text] [Related]  

  • 17. Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: A new syndrome?
    Viana MB; Carvalho RI
    J Pediatr; 1978 Aug; 93(2):235-8. PubMed ID: 671156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
    Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
    Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects.
    Chuang DT; Niu WL; Cox RP
    Biochem J; 1981 Oct; 200(1):59-67. PubMed ID: 6895847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.